Advanced company searchLink opens in new window

GITLIFE BIOTECH LTD

Company number 14690170

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
02 Oct 2024 TM01 Termination of appointment of Nadia Rostami as a director on 30 September 2024
02 Oct 2024 AA Total exemption full accounts made up to 29 February 2024
10 Jul 2024 CS01 Confirmation statement made on 5 July 2024 with updates
24 May 2024 CH01 Director's details changed for Mr Alastair Orr Ewing on 22 May 2024
14 Mar 2024 SH01 Statement of capital following an allotment of shares on 22 February 2024
  • GBP 107.6705
22 Nov 2023 AP01 Appointment of Mr Alastair Orr Ewing as a director on 15 November 2023
01 Nov 2023 SH01 Statement of capital following an allotment of shares on 31 August 2023
  • GBP 96.1109
01 Nov 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
01 Nov 2023 SH01 Statement of capital following an allotment of shares on 22 September 2023
  • GBP 107.2217
01 Nov 2023 MA Memorandum and Articles of Association
12 Jul 2023 MA Memorandum and Articles of Association
12 Jul 2023 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
06 Jul 2023 PSC02 Notification of Newcastle University Holdings Limited as a person with significant control on 3 July 2023
05 Jul 2023 CS01 Confirmation statement made on 5 July 2023 with updates
05 Jul 2023 PSC04 Change of details for Dr Natalio Krasnogor as a person with significant control on 3 July 2023
03 Jul 2023 SH01 Statement of capital following an allotment of shares on 3 July 2023
  • GBP 85
27 Feb 2023 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2023-02-27
  • GBP 33.5